VCRIX
Price
$14.50
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Net Assets
933.13M
VCRVX
Price
$14.48
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Net Assets
933.13M
Interact to see
Advertisement

VCRIX vs VCRVX

Header iconVCRIX vs VCRVX Comparison
Open Charts VCRIX vs VCRVXBanner chart's image
NYLI CBRE Global Infrastructure
Price$14.50
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets933.13M
NYLI CBRE Global Infrastructure Inv Cl
Price$14.48
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets933.13M
VCRIX vs VCRVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VCRIX vs. VCRVX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VCRIX is a Buy and VCRVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VCRIX (933M) and VCRVX (933M) have equal amount of cash in the bank . VCRIX pays higher dividends than VCRVX: VCRIX (2.07) vs VCRVX (1.74). VCRIX was incepted earlier than VCRVX: VCRIX (12 years) vs VCRVX (5 years). VCRVX (1.35) is less costly to investors than VCRIX (1.03). VCRIX (47.00) and VCRVX (47.00) have comparable annual turnover. VCRVX has a lower initial minimum investment than VCRIX: VCRVX (1000) vs VCRIX (1000000). VCRIX (16.92) and VCRVX (16.53) have marching annual gain over last year. VCRIX return over 5 years is better than : 43.78 vs. VCRVX (41.49).
VCRIXVCRVXVCRIX / VCRVX
Total Expense Ratio0.971.3572%
Annual Report Gross Expense Ratio1.031.3576%
Fund Existence12 years5 years-
Gain YTD12.37012.208101%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets933M933M100%
Annual Yield % from dividends2.071.74119%
Returns for 1 year16.9216.53102%
Returns for 3 years22.1720.88106%
Returns for 5 years43.7841.49106%
Returns for 10 years57.70N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV1.430.04
+2.88%
Acrivon Therapeutics
TKR81.660.90
+1.11%
Timken Company (The)
SERA3.25N/A
N/A
Sera Prognostics
VERA21.81-0.07
-0.32%
Vera Therapeutics
NOW968.79-27.39
-2.75%
SERVICENOW